CME Group Inc. (NASDAQ:CME) Shares Sold by Voloridge Investment Management LLC

Voloridge Investment Management LLC trimmed its position in CME Group Inc. (NASDAQ:CME - Free Report) by 51.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 473,248 shares of the financial services provider's stock after selling 505,574 shares during the period. Voloridge Investment Management LLC owned 0.13% of CME Group worth $109,902,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently made changes to their positions in the company. Lake Street Advisors Group LLC increased its position in shares of CME Group by 108.7% in the 4th quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider's stock valued at $2,949,000 after acquiring an additional 6,453 shares during the period. Unified Investment Management acquired a new stake in CME Group during the 4th quarter worth about $503,000. Spire Wealth Management grew its position in CME Group by 37.4% during the 4th quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider's stock worth $307,000 after purchasing an additional 359 shares during the period. AEGON ASSET MANAGEMENT UK Plc grew its position in CME Group by 19.3% during the 4th quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider's stock worth $75,730,000 after purchasing an additional 52,862 shares during the period. Finally, Aspire Growth Partners LLC acquired a new stake in CME Group during the 4th quarter worth about $548,000. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Trading Up 0.6%

CME stock opened at $277.94 on Tuesday. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $286.48. The stock has a market cap of $100.16 billion, a price-to-earnings ratio of 28.74, a PEG ratio of 6.76 and a beta of 0.45. The business's 50-day moving average is $266.29 and its 200 day moving average is $247.71.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.61 by $0.19. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The company had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.56 billion. During the same period in the previous year, the firm posted $2.50 EPS. CME Group's revenue was up 10.4% compared to the same quarter last year. On average, sell-side analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be issued a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.80%. The ex-dividend date of this dividend is Monday, June 9th. CME Group's payout ratio is 50.30%.

Insider Buying and Selling

In other CME Group news, insider Hilda Harris Piell sold 3,984 shares of the firm's stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total value of $997,872.48. Following the transaction, the insider now directly owns 27,046 shares of the company's stock, valued at $6,774,211.62. This trade represents a 12.84% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Howard J. Siegel sold 10,000 shares of the firm's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the completion of the transaction, the director now directly owns 21,873 shares in the company, valued at $5,686,980. This trade represents a 31.37% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 26,434 shares of company stock worth $6,987,065. Insiders own 0.30% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Barclays increased their price target on CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a research report on Wednesday, April 23rd. Oppenheimer increased their price target on CME Group from $269.00 to $279.00 and gave the stock an "outperform" rating in a research report on Friday, April 11th. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $269.00 price target on shares of CME Group in a research report on Thursday, April 3rd. Erste Group Bank raised CME Group to a "strong-buy" rating in a research report on Monday, March 17th. Finally, Raymond James upgraded CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 target price on the stock in a research report on Monday, March 10th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $256.80.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.